Cystic fibrosis drugs to be available on NHS in England within 30 days

Every patient in England with cystic fibrosis who could benefit from one of the new precision drugs that target certain mutations underlying the condition will have access to them within 30 days, NHS England has said after striking a deal with the US manufacturer Vertex Pharmaceuticals. Last July it...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BMJ (Online) 2019-10, Vol.367, p.l6206-l6206
1. Verfasser:	Kmietowicz, Zosia
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics Cystic fibrosis Drugs Stevens, Simon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!